Keros Therapeutics announced that it will not be participating in the previously announced fireside chat presentation during the Goldman Sachs 44th Annual Healthcare Conference on Wednesday, June 14, 2023.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on KROS:
- Keros Therapeutics Announces Update to Participation at the Goldman Sachs 44th Annual Global Healthcare Conference
- Keros Therapeutics Presents Clinical Trial and Preclinical Study Results from its KER-050 Program and Preclinical Data from its ALK2 Inhibitor Program at the 28th Annual Congress of the European Hematology Association
- Keros Therapeutics to Present at Goldman Sach’s 44th Annual Global Healthcare Conference
- Keros Therapeutics Presents Preclinical and Clinical Data from its KER-012 Program at the American Thoracic Society International Conference
- Keros Therapeutics to Present at the 28th Annual Congress of the European Hematology Association